Skip to main content
OpenTrials

Clinical trial condition

Cytopenia

Explore clinical trials studying Cytopenia. Study availability and eligibility vary by location and protocol.

1,026 public trials 195 recruiting studies
Refine in advanced search Browse all conditions

Cytopenia trial results

Recruiting

Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)

NCT06371417

Conditions
Antiphospholipid Syndrome, Antiphospholipid Syndrome (APS), Autoimmune Diseases, +50 more
Locations
  • University of California-Irvine Orange, California, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Northwell Health, LLC PRIME Lake Success, New York, United States
  • Hospital for Special Surgery New York, United States
View all 77 locations
View Trial Details
Recruiting

Study of Ianalumab in Adults With Primary Immune Thrombocytopenia (ITP) and Warm-antibody Autoimmune Hemolytic Anemia (wAIHA) Who Have Previously Benefited From Ianalumab

NCT07039422

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +17 more
Locations
  • Novartis Investigative Site Buenos Aires, Argentina
  • Novartis Investigative Site Roeselare, West-Vlaanderen, Belgium
  • Novartis Investigative Site Guangzhou, Guangdong, China
  • Novartis Investigative Site Dalian, Liaoning, China
View all 25 locations
View Trial Details
Recruiting

Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia

NCT06722586

Conditions
Antiphospholipid (aPL)-Positive, Blood Platelet Disorders, Cytopenia, +4 more
Locations
  • Xiangya Hospital of Central South University Changsha, Hunan, China
  • Qilu Hospital of Shandong University Jinan, Shangdong, China
  • West China Hospital, Sichuan University Chengdu, Sichuan, China
  • People's Hospital of Xinjiang Uygur Autonomous Region Ürümqi, Xinjiang, China
View Trial Details
Recruiting

Study to Evaluate the Efficacy and Safety of Oral Rilzabrutinib in Adults With Immune Thrombocytopenia (ITP) Who Failed First-line Treatment

NCT07007962

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Community Health Partners (CHP) - Community Medical Oncology Specialists (University Oncology Associates) Clovis, California, United States
  • University of Southern California (USC) Los Angeles, California, United States
  • Tulane University Health Sciences Center - Tulane Avenue-Investigational Site Number: 8400011 New Orleans, Louisiana, United States
  • Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States
View all 36 locations
View Trial Details
Recruiting

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

NCT04098445

Conditions
Blood Platelet Disorders, Bronchial Diseases, Bronchiolitis, +14 more
Locations
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Dana-Farber Cancer Institute/Boston Children's Hospital Boston, Massachusetts, United States
  • University of Minnesota Minneapolis, Minnesota, United States
View Trial Details

Related conditions